ArticleFrontiers in endocrinology2025

Real-world efficacy of MiniMed™780G recommended settings (glycemic target 100 mg/dL, active insulin time 2 hours) in youth and young adults with type 1 diabetes.

Marta Bassi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.